Acrivon Therapeutics (ACRV.US) Shareholder Detail - Holdings History & Trades | Longbridge

GC

Geode Capital Management, LLC

BuySellPriceUnit: Shares

Holdings History

Date
Latest	<0.01%	+28.85K	0.62%	265.24K	06/30/2026
Q2 2026	<0.01%	+28.85K	0.62%	265.24K	06/30/2026
Q1 2026	0.02%	+38.17K	0.61%	236.39K	03/31/2026
Q4 2025	0.02%	+6.19K	0.63%	198.22K	12/31/2025
Q3 2025	0.09%	+27.67K	0.61%	192.03K	09/30/2025
Q2 2025	0.45%	-141.75K	0.52%	164.36K	06/30/2025
Q1 2025	0.01%	+4.72K	0.98%	306.11K	03/31/2025
Q4 2024	<0.01%	-714.00	0.97%	301.39K	12/31/2024
Q3 2024	0.03%	-6.29K	0.97%	302.10K	09/30/2024
Q2 2024	0.08%	+65.55K	1.00%	308.39K	06/30/2024
Q1 2024	0.23%	+53.65K	1.07%	242.85K	03/31/2024
Q4 2023	0.02%	-359.00	0.84%	189.20K	12/31/2023
Q3 2023	0.05%	+11.11K	0.86%	189.56K	09/30/2023
Q2 2023	<0.01%	+3.05K	0.81%	178.45K	06/30/2023
Q1 2023	--	+175.40K	0.80%	175.40K	03/31/2023